Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

42.75p
   
  • Change Today:
      0.75p
  • 52 Week High: 48.40
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 2,754,763
  • Market Cap: £231.09m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.
Registrars: Capita Registrars

Key Personnel

CEO: Nick Sedgwick
CFO: Andrew Franklin
Chairman: Camillo Pane
Chief Operating Officer: Jeyan Heper
Independent Non-Executive Director: Kristof Neirynck
Independent Non-Executive Director: Martin Sutherland
Senior Independent Director: Richard Jones
Non-Executive Dir: Eva-Lotta Sjöstedt, Richard McKenzie

Contact Details

Address: Avonbridge House, Bath Road, Chippenham, Wiltshire, United Kingdom, SN15 2BB
Phone: +44 (0)1249 466966
Fax: +44 (0)1249 466977
Website: http://www.alliancepharma.co.uk

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0031030819

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 42.75p
Change Today 0.75p
% Change 1.79 %
52 Week High 48.40
52 Week Low 29.35
Volume 2,754,763
Shares Issued 540.57m
Market Cap £231.09m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.58% above the market average12.58% above the market average12.58% above the market average12.58% above the market average12.58% above the market average
91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average
Price Trend
22.33% below the market average22.33% below the market average22.33% below the market average22.33% below the market average22.33% below the market average
22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average
Income Not Available
Growth
41.79% below the market average41.79% below the market average41.79% below the market average41.79% below the market average41.79% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 11-Sep-2024

Time Volume / Share Price
17:06 599,486 @ 42.75p
16:35 5,829 @ 42.75p
16:35 16,799 @ 42.75p
16:35 109,149 @ 42.75p
16:35 1 @ 42.75p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page